These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31886666)

  • 1. Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer.
    Alakwaa FM; Savelieff MG
    J Proteome Res; 2020 Jul; 19(7):2879-2889. PubMed ID: 31886666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.
    Budczies J; Brockmöller SF; Müller BM; Barupal DK; Richter-Ehrenstein C; Kleine-Tebbe A; Griffin JL; Orešič M; Dietel M; Denkert C; Fiehn O
    J Proteomics; 2013 Dec; 94():279-88. PubMed ID: 24125731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
    Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
    Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fingerprinting in breast cancer stages through
    Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
    J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A joint analysis of metabolomics and genetics of breast cancer.
    Tang X; Lin CC; Spasojevic I; Iversen ES; Chi JT; Marks JR
    Breast Cancer Res; 2014 Aug; 16(4):415. PubMed ID: 25091696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
    Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
    Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer.
    Gal J; Bailleux C; Chardin D; Pourcher T; Gilhodes J; Jing L; Guigonis JM; Ferrero JM; Milano G; Mograbi B; Brest P; Chateau Y; Humbert O; Chamorey E
    Comput Struct Biotechnol J; 2020; 18():1509-1524. PubMed ID: 32637048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
    Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
    Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
    Yang Y; Zhu Y; Li X; Zhang X; Yu B
    Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic characterization of triple negative breast cancer.
    Cao MD; Lamichhane S; Lundgren S; Bofin A; Fjøsne H; Giskeødegård GF; Bathen TF
    BMC Cancer; 2014 Dec; 14():941. PubMed ID: 25495193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
    Huang R; Ding P; Yang F
    Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of Transcriptome and Metabolome Provides Unique Insights to Pathways Associated With Obese Breast Cancer Patients.
    Hassan MA; Al-Sakkaf K; Shait Mohammed MR; Dallol A; Al-Maghrabi J; Aldahlawi A; Ashoor S; Maamra M; Ragoussis J; Wu W; Khan MI; Al-Malki AL; Choudhry H
    Front Oncol; 2020; 10():804. PubMed ID: 32509585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.
    Dugo M; Huang X; Iorio MV; Cataldo A; Tagliabue E; Daidone MG; Wu J; Orlandi R
    Breast; 2018 Jun; 39():46-52. PubMed ID: 29597130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
    Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
    Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study.
    Harada-Shoji N; Soga T; Tada H; Miyashita M; Harada M; Watanabe G; Hamanaka Y; Sato A; Suzuki T; Suzuki A; Ishida T
    Metabolomics; 2019 Nov; 15(11):147. PubMed ID: 31686242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data.
    Alakwaa FM; Chaudhary K; Garmire LX
    J Proteome Res; 2018 Jan; 17(1):337-347. PubMed ID: 29110491
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.